117 results on '"Anampa,Jesus"'
Search Results
2. Benefit of adjuvant chemotherapy in lymph node-negative, T1b and T1c triple-negative breast cancer
3. Racial disparities in treatment and outcomes between non-Hispanic Black and non-Hispanic White women with nonmetastatic inflammatory breast cancer
4. Trends in Incidence of Invasive Lobular Carcinoma of the Breast by Race: Patterns by Age, Cancer Stage, and Socioeconomic Factors in the United States, 1992-2019
5. Assessment of Use and Impact of Chemotherapy in Lymph Node-Negative, T1a Triple-Negative Breast Cancer
6. Racial disparities in overall survival after the introduction of cyclin-dependent kinase 4/6 inhibitors for patients with hormone receptor-positive, HER2-negative metastatic breast cancer
7. Racial disparities in neutrophil counts among patients with metastatic breast cancer during treatment with CDK4/6 inhibitors
8. The TAB-EOAO study: Trends in use and benefit of adjuvant chemotherapy between early onset and average onset locally advanced colon cancer.
9. Treatment and Survival Differences between Patients with Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma of the Breast.
10. Assessment of MRI to estimate metastatic dissemination risk and prometastatic effects of chemotherapy
11. HOLA COVID-19 Study: Evaluating the Impact of Caring for Patients With COVID-19 on Cancer Care Delivery in Latin America
12. Phase I Trial of Veliparib, a Poly ADP Ribose Polymerase Inhibitor, Plus Metronomic Cyclophosphamide in Metastatic HER2-negative Breast Cancer
13. Benefit of adjuvant chemotherapy in lymph node-negative, T1b and T1c triple-negative breast cancer
14. Human Immunodeficiency Virus (HIV) Infection and Cancer
15. Contributors
16. Anthracycline Use for Early Stage Breast Cancer in the Modern Era: a Review
17. Racial disparities in overall survival after the introduction of cyclin-dependent kinase 4/6 inhibitors for patients with hormone receptor-positive, HER2-negative metastatic breast cancer
18. Tailoring Adjuvant Therapy for Breast Cancer in the Elderly: Room for Improvement
19. The landscape of systemic therapy for early stage triple-negative breast cancer
20. Efficacy of booster doses in augmenting waning immune responses to COVID-19 vaccine in patients with cancer
21. Abstract P3-12-26: Baseline characteristics and survival of neuroendocrine carcinoma of the breast- A SEER database analysis
22. Racial Disparities in Neutrophil Counts Among Patients with Metastatic Breast Cancer during Treatment with CDK4/6 Inhibitors
23. Pregnancy-Associated Autoimmune Hemolytic Anemia: Meta-Analysis of Clinical Characteristics, Maternal and Neonatal Outcomes
24. Unusual cause of cholestatic jaundice in a patient with AIDS
25. 62 - Human Immunodeficiency Virus (HIV) Infection and Cancer
26. Abstract PS4-30: Neutrophil-to-lymphocyte ratio or platelet-to-lymphocyte ratio as prognostic biomarkers in patients with metastatic breast cancer treated with CDK4/6 inhibitors
27. Breast cancer in patients with Li–Fraumeni syndrome – a case-series study and review of literature
28. Abstract P3-08-24: Racial disparities in neutrophil counts among patients with metastatic breast cancer during treatment with CDK4/6 inhibitors
29. Applying the Hippocratic Oath in breast cancer-The case for promoting prevention
30. Abstract CT021: Phase Ib study of rebastinib plus antitubulin therapy with paclitaxel (P) or eribulin (E) in patients with HER2 negative metastatic breast cancer (MBC)
31. Abstract 67: Chemotherapy induced pro-metastatic changes in the primary breast tumors of racially diverse patients
32. Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemia
33. Colaboradores
34. 62 - Infección por el virus de la inmunodeficiencia humana (VIH) y cáncer
35. Dual Inhibition of Mdmx and Mdm2 Using an Alpha-Helical P53 Stapled Peptide (ALRN-6924) As a Novel Therapeutic Strategy in Acute Myeloid Leukemia
36. Macrocytosis and dysplastic anemia is associated with the cyclin-dependent kinase 4/6 inhibitor palbociclib in metastatic breast cancer
37. New agents for the management of resistant metastatic breast cancer
38. Dual inhibition of HDMX and HDM2 in acute myeloid leukemia
39. Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism
40. Abstract CT040: Phase Ib study of rebastinib plus antitubulin therapy with paclitaxel or eribulin in patients with metastatic breast cancer
41. Abstract 3963: Neoadjuvant chemotherapy promotes prometastatic changes in the primary breast tumor microenvironment in mice and humans
42. Breast cancer in patients with Li–Fraumeni syndrome – a case-series study and review of literature
43. Tailoring Adjuvant Therapy for Breast Cancer in the Elderly: Room for Improvement
44. Abstract 244: Paclitaxel increases the assembly and function of the tumor microenvironment of metastasis in breast cancer
45. Progress in adjuvant chemotherapy for breast cancer: an overview
46. Enhancing evaluation of cancer cachexia (CC) and sarcopenia through skeletal muscle mass (SMM) determination in patients (pts) with non-small cell lung cancer (NSCLC), assessing at the L1 level on routine chest CT: A prospective study of accuracy for cancer patients.
47. First Report of Reversible Macrocytic Anemia with Dysplastic Features Associated with Palbociclib Use in Patients with Metastatic Breast Cancer
48. The Evolving Adjuvant Treatment Landscape in Patients with Early Breast Cancer
49. Unusual cause of cholestatic jaundice in a patient with AIDS.
50. Phase Ib Clinical and Pharmacodynamic Study of the TIE2 Kinase Inhibitor Rebastinib with Paclitaxel or Eribulin in HER2-Negative Metastatic Breast Cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.